EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy

Yingxin Tian, Yiming Ni, Ting Zhang, Yemin Cao, Mingmei Zhou, Cheng Zhao

Frontiers in Cell and Developmental Biology · 05.09.2024 · 12

DOI: 10.3389/fcell.2024.1444198 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 05.09.2024. Verfasst von Yingxin Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Traditional Chinese Medicine Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) and its more advanced form, non-alcoholic steatohepatitis (NASH), have become global health challenges with significant morbidity and mortality rates. NAFLD encompasses several liver diseases, ranging from simple steatosis to more severe inflammatory and fibrotic forms. Ultimately, this can lead to liver cirrhosis and hepatocellular carcinoma. The intricate role of hepatic macrophages, particularly Kupffer cells (KCs) and monocyte-derived macrophages (MoMFs), in the pathogenesis of NAFLD and NASH, has received increasing attention. Hepatic macrophages can interact with hepatocytes, hepatic stellate cells, and endothelial cells, playing a crucial role in maintaining homeostasis. Paradoxically, they also participate in the pathogenesis of some liver diseases. This review highlights the fundamental role of hepatic macrophages in the pathogenesis of NAFLD and NASH, emphasizing their plasticity and contribution to inflammation and fibrosis, and hopes to provide ideas for subsequent experimental research and clinical treatment.

Schlagwörter

Stichwörter der Autor:innen

Kupffer cells (KCs)NASHmacrophagesmonocyte-derived macrophages (MoMFs)non-alcoholic fatty liver disease (NAFLD)

Autor:innen und Institutionen

  • Shanghai Traditional Chinese Medicine Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Zitieren

APA

Tian, Y., Ni, Y., Zhang, T., Cao, Y., Zhou, M., & Zhao, C. (2024). Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1444198

Vancouver

Tian Y, Ni Y, Zhang T, Cao Y, Zhou M, Zhao C. Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1444198

BibTeX
@article{Tian2024,
  author = {Tian, Yingxin and Ni, Yiming and Zhang, Ting and Cao, Yemin and Zhou, Mingmei and Zhao, Cheng},
  title = {Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1444198}
}
Kostenlos starten →